EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 3.0

Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy

Esteban Cruz, Veysel Kayser

Biologics: Targets and Therapy · 2019-05 · Volume 13 · 33-51

DOI: 10.2147/btt.s166310 ↗

At a glance

Übersichtsarbeit in Biologics: Targets and Therapy, 2019-05. Written by Esteban Cruz and 1 co-authors. Institution: School of Pharmacy, The University of Sydney, Sydney, NSW, Australia. Cited 121 times so far (Crossref). The full text is freely available (open access, CC BY-NC 3.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Není k dispozici žádný abstrakt.

Subjects

Author keywords

antibody therapyantibody–drug conjugatesimmune checkpoint inhibitorsnanoparticle delivery vehiclestreatment resistance

Authors and institutions

  • School of Pharmacy, The University of Sydney, Sydney, NSW, Australia.

Cite

APA

Cruz, E., & Kayser, V. (2019). Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy. Biologics: Targets and Therapy, Volume 13, 33-51. https://doi.org/10.2147/btt.s166310

Vancouver

Cruz E, Kayser V. Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy. Biologics: Targets and Therapy. 2019;Volume 13:33-51. doi:10.2147/btt.s166310

BibTeX
@article{Cruz2019,
  author = {Cruz, Esteban and Kayser, Veysel},
  title = {Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy},
  journal = {Biologics: Targets and Therapy},
  year = {2019},
  volume = {Volume 13},
  pages = {33--51},
  doi = {10.2147/btt.s166310}
}
Start for free →